Skip to main content
Skip to footer
Home
News Channels
Antibodies
Proteins and Peptides
Vaccines
DNA RNA and Cells
Small Molecules
More News
All News
Reports
Press Room
Contact Us
About Us
Search ...
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Results
Reports
Mar 2024
CD38-Targeted Antibody & Cell Therapy Pipeline Review
300,00€
Mar 2024
TL1A Inhibitor Pipeline Review
100,00€
Mar 2024
5T4-Targeted Immunotherapy Candidates Pipeline Review
100,00€
Mar 2024
2023 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
130,00€
Mar 2024
Biologics Sales Database for Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and RNA
250,00€
Jan 2024
GPC3-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
Her3-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
TROP-2-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
Nectin-4-Targeted Immunotherapy Pipeline Review
200,00€
Nov 2023
DLL3-Targeted Immunotherapy Candidates Pipeline Review
200,00€
Nov 2023
B7-H3-Targeted Immunotherapy Candidates Pipeline Review
300,00€
Oct 2023
EpCAM-Targeted Antibodies Pipeline Review
200,00€
Oct 2023
PD-1 Agonists Pipeline Review
200,00€
Sep 2023
c-Met-Targeted Antibody Therapy Pipeline Review
300,00€
Sep 2023
PSMA-Targeted Therapy Pipeline Review
400,00€
Sep 2023
Mesothelin-Targeted Immunotherapy Pipeline Review
300,00€
Sep 2023
CCR8-Targeted Antibody Immunotherapy Pipeline Review
300,00€
Aug 2023
Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective
2.150,00€
Aug 2023
CD40 Agonists & CD40/L Antagonists Pipeline Review
300,00€
Aug 2023
Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review
300,00€
Aug 2023
Folate Receptor alpha (FRα) Targeted Therapy Pipeline Review
300,00€
Aug 2023
IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review
300,00€
Jul 2023
Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review
300,00€
Jul 2023
Competitor Analysis: Complement C5 Inhibitors & C5 Receptor Antagonists
400,00€
Jul 2023
Adalimumab (Humira) Biosimilars Pipeline Review
400,00€
1
2
3
→
Search ...
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
2023 Sales of
Antibodies & Proteins
Get it now.